| 1 |
Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
Jan B. Vermorken, Ricard Mesı́a, Fernando Rivera et al. · New England Journal of Medicine
Open access |
10 Sep 2008 |
3,762 |
| 2 |
Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic Leukemia
Rajendra N. Damle, Tarun Wasil, Franco Fais et al. · Blood
|
15 Sep 1999 |
2,607 |
| 3 |
Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis
Alessandro Moretta, Cristina Bottino, Massimo Vitale et al. · Annual Review of Immunology
Review |
Apr 2001 |
1,785 |
| 4 |
HUMN project: detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures
Michael Felix Fenech, Wushou P. Chang, Micheline Kirsch‐Volders et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis
|
28 Dec 2002 |
1,395 |
| 5 |
Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium
Graziella Pellegrini, Carlo Enrico Traverso, Adriano Tito Franzi et al. · The Lancet
|
Apr 1997 |
1,387 |
| 6 |
Repair of Large Bone Defects with the Use of Autologous Bone Marrow Stromal Cells
Rodolfo Quarto, Maddalena Mastrogiacomo, Ranieri Cancedda et al. · New England Journal of Medicine
|
Feb 2001 |
1,379 |
| 7 |
Capecitabine as Adjuvant Treatment for Stage III Colon Cancer
Chris J. Twelves et al. · New England Journal of Medicine
Open access |
29 Jun 2005 |
1,256 |
| 8 |
Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial
Arnaud D. Roth, Sabine Tejpar, Mauro Delorenzi et al. · Journal of Clinical Oncology
|
15 Dec 2009 |
1,168 |
| 9 |
Mesenchymal stem cells inhibit natural killer–cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2
Grazia Maria Spaggiari, Andrea Capobianco, Heba Abdelrazik et al. · Blood
|
19 Oct 2007 |
1,157 |
| 10 |
Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells
Guido Ferlazzo, Ming Li Tsang, Lorenzo Moretta et al. · The Journal of Experimental Medicine
Open access |
4 Feb 2002 |
986 |
| 11 |
Cancer incidence and mortality in Europe
Fabio Levi, Patrick Maisonneuve, Rosangela Filiberti et al. · Sozial- und Präventivmedizin
|
Mar 1989 |
971 |
| 12 |
Five Years of Letrozole Compared With Tamoxifen As Initial Adjuvant Therapy for Postmenopausal Women With Endocrine-Responsive Early Breast Cancer: Update of Study BIG 1-98
Alan Stuart Coates, Aparna P. Keshaviah, Beat J. K. Thurlimann et al. · Journal of Clinical Oncology
|
2 Jan 2007 |
911 |
| 13 |
Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors.
Franco Fais, Fabio Ghiotto, Shiori Hashimoto et al. · Journal of Clinical Investigation
Open access |
15 Oct 1998 |
886 |
| 14 |
AU Binding Proteins Recruit the Exosome to Degrade ARE-Containing mRNAs
Ching‐Yi Chen, Roberto Gherzi, Shao‐En Ong et al. · Cell
Open access |
Nov 2001 |
880 |
| 15 |
Identification of PVR (CD155) and Nectin-2 (CD112) as Cell Surface Ligands for the Human DNAM-1 (CD226) Activating Molecule
Cristina Bottino, Roberta Castriconi, Daniela Pende et al. · The Journal of Experimental Medicine
Open access |
11 Aug 2003 |
868 |
| 16 |
Early Interim 2-[ 18 F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: A Report From a Joint Italian-Danish Study
Andrea Gallamini, Martin Hutchings, Luigi Rigacci et al. · Journal of Clinical Oncology
|
23 Jul 2007 |
846 |
| 17 |
Consensus guidelines for the detection of immunogenic cell death
Oliver Kepp et al. · OncoImmunology
Open access |
2 Sep 2014 |
842 |
| 18 |
Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen
Mitch Dowsett, Jack M. Cuzick, J. N. Ingle et al. · Journal of Clinical Oncology
Review |
30 Nov 2009 |
818 |
| 19 |
Differential requirement for the activation of the inflammasome for processing and release of IL-1β in monocytes and macrophages
Mihai Gheorghe Netea, Claudia A. Nold‐Petry, Marcel F. Nold et al. · Blood
Open access |
22 Dec 2008 |
795 |
| 20 |
A novel secretory pathway for interleukin‐1 beta, a protein lacking a signal sequence.
Anna Rubartelli, Federico Cozzolino, M. Talio et al. · The EMBO Journal
Open access |
May 1990 |
787 |
| 21 |
Autologous Transplantation and Maintenance Therapy in Multiple Myeloma
Antonio Palumbo et al. · New England Journal of Medicine
Open access |
3 Sep 2014 |
786 |
| 22 |
Identification and Molecular Characterization of Nkp30, a Novel Triggering Receptor Involved in Natural Cytotoxicity Mediated by Human Natural Killer Cells
Daniela Pende, Silvia Parolini, Anna Maria Pessino et al. · The Journal of Experimental Medicine
Open access |
15 Nov 1999 |
785 |
| 23 |
Adjuvant Mitotane Treatment for Adrenocortical Carcinoma
Massimo Terzolo et al. · New England Journal of Medicine
Open access |
6 Jun 2007 |
766 |
| 24 |
Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells
Andrea Banfi, Anita Muraglia, Béatrice Dozin et al. · Experimental Hematology
Open access |
Jun 2000 |
731 |
| 25 |
The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs
Michèle Trabucchi, Paola Briata, MaríaFlor García-Mayoral et al. · Nature
Open access |
20 May 2009 |
657 |
| 26 |
Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulin.
Chao‐Kai Chou, Thomas J. Dull, David Russell et al. · Journal of Biological Chemistry
Open access |
Feb 1987 |
649 |
| 27 |
Allele-specific enzymatic amplification of beta-globin genomic DNA for diagnosis of sickle cell anemia.
Dan Y. Wu, Luis A. Ugozzoli, B K Pal et al. · Proceedings of the National Academy of Sciences
Open access |
Apr 1989 |
629 |
| 28 |
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value.
Loredana Ruggeri, Antonella Mancusi, Marusca Capanni et al. · Blood
Open access |
19 Mar 2007 |
611 |
| 29 |
The HUman MicroNucleus Project—An international collaborative study on the use of the micronucleus technique for measuring DNA damage in humans
Michael Felix Fenech, Nina Holland, Wushou Peter Chang et al. · Mutation research. Fundamental and molecular mechanisms of mutagenesis
|
Jul 1999 |
607 |
| 30 |
Stem Cells Associated with Macroporous Bioceramics for Long Bone Repair: 6- to 7-Year Outcome of a Pilot Clinical Study
Maurilio Marcacci, Elizaveta Kon, Vladimir Moukhachev et al. · Tissue Engineering
|
20 Mar 2007 |
588 |
| 31 |
SOX2 Silencing in Glioblastoma Tumor-Initiating Cells Causes Stop of Proliferation and Loss of Tumorigenicity
Rosaria M. R. Gangemi, Fabrizio Griffero, Daniela Marubbi et al. · Stem Cells
|
24 Oct 2008 |
583 |
| 32 |
Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs
Guido Ferlazzo, Maggi Pack, Dolca A. Thomas et al. · Proceedings of the National Academy of Sciences
Open access |
9 Nov 2004 |
578 |
| 33 |
The Abundant NK Cells in Human Secondary Lymphoid Tissues Require Activation to Express Killer Cell Ig-Like Receptors and Become Cytolytic
Guido Ferlazzo, Dolca A. Thomas, Shao‐Lee Lin et al. · The Journal of Immunology
Open access |
Feb 2004 |
578 |
| 34 |
Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains
Nicolai R. Wagtmann, Roberto Biassoni, Claudia Cantoni et al. · Immunity
Open access |
May 1995 |
577 |
| 35 |
Trastuzumab-Associated Cardiac Adverse Effects in the Herceptin Adjuvant Trial
Thomas Suter, Marion Jennifer Procter, Dirk J. van Veldhuisen et al. · Journal of Clinical Oncology
Open access |
24 Jul 2007 |
568 |
| 36 |
Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors
Sebastian Giebel · Blood
|
3 Apr 2003 |
551 |
| 37 |
A case‐control study of gastric cancer and diet in Italy
Eva Buiatti, Domenico Palli, Adriano Decarli et al. · International Journal of Cancer
|
15 Oct 1989 |
548 |
| 38 |
A tissue engineering approach to bone repair in large animal models and in clinical practice
Ranieri Cancedda, Paolo Giannoni, Maddalena Mastrogiacomo · Biomaterials
|
18 Jul 2007 |
543 |
| 39 |
Identification of a Wnt/Dvl/β-Catenin → Pitx2 Pathway Mediating Cell-Type-Specific Proliferation during Development
Chrissa Kioussi, Paola Briata, Sung Hee Baek et al. · Cell
Open access |
Nov 2002 |
542 |
| 40 |
The Receptor with High Affinity for Immunoglobulin E
H. Peter Metzger, Gisèle Alcaraz, Robert J. Hohman et al. · Annual Review of Immunology
|
Apr 1986 |
541 |
| 41 |
Two Pathways for Base Excision Repair in Mammalian Cells
Guido Fròsina, Paola Fortini, Ottavio Rossi et al. · Journal of Biological Chemistry
Open access |
Apr 1996 |
536 |
| 42 |
CRTAP Is Required for Prolyl 3- Hydroxylation and Mutations Cause Recessive Osteogenesis Imperfecta
Roy Morello, Terry Bertin, Yuqing Chen et al. · Cell
Open access |
Oct 2006 |
534 |
| 43 |
First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous5-fluorouracil/leucovorin
Jim Cassidy, Chris J. Twelves, Eric Van Cutsem et al. · Annals of Oncology
Open access |
Apr 2002 |
529 |
| 44 |
Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients.
Luigi Solbiati, Tiziana Ierace, Shraga Nahum Goldberg et al. · Radiology
|
1997 |
526 |
| 45 |
Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial
B-J Kullberg, JD Sobel, Markus Ruhnke et al. · The Lancet
|
Oct 2005 |
525 |
| 46 |
Association of Type and Location ofBRCA1andBRCA2Mutations With Risk of Breast and Ovarian Cancer
Timothy R. Rebbeck et al. · JAMA
Open access258 authors |
7 Apr 2015 |
517 |
| 47 |
Role of scaffold internal structure on in vivo bone formation in macroporous calcium phosphate bioceramics
Maddalena Mastrogiacomo, Silvia Scaglione, Roberta Martinetti et al. · Biomaterials
|
21 Feb 2006 |
513 |
| 48 |
Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.
Daniela Pende, Paola Rivera, Stefania Marcenaro et al. · PubMed
|
Nov 2002 |
505 |
| 49 |
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial
Alessandro Gronchi et al. · The Lancet Oncology
|
9 May 2017 |
498 |
| 50 |
Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European Study Group on Cytogenetic Biomarkers and Health.
Stefano Bonassi, Lars Hagmar, Ulf Strömberg et al. · PubMed
|
15 Mar 2000 |
495 |